The post describes tirzepatide as a complex peptide prone to breaking down when made, and raises questions about versions mixed with vitamin B12.
Recap by typeshit. Post by Facebook on Facebook.
WebMD notes that eating less on a GLP-1 can mean missing some nutrients, and suggests asking your doctor about nutrition while on the drug.
The FDA notice says the pharmacy can't assure the vials are sterile. Check the full details to see which compounded products are affected.
Doctors describe a patient who developed a bowel obstruction after moving from tirzepatide to semaglutide unsupervised, following a long break in treatment.
PIX11 reports the recall covers 23 compounded GLP-1 vials because there is no assurance they are sterile. Check the list if you use compounded shots.
Rachel Cohrs Zhang reports agency leaders are trying to square Kennedy's plan to widen peptide access with concerns from FDA scientists.
Bloomberg reports the Kennedy plan to widen peptide access comes with a side effect reporting rule for compounding pharmacies.
Loading…